Narayana Cheedarla
Narayana Cheedarla
Assistant Scientist
Verified email at
Cited by
Cited by
Systemic inflammation and the increased risk of inflamm-aging and age-associated diseases in people living with HIV on long term suppressive antiretroviral therapy
H Babu, AT Ambikan, EE Gabriel, S Svensson Akusjärvi, AN Palaniappan, ...
Frontiers in immunology 10, 1965, 2019
Multiple NF-κB sites in HIV-1 subtype C long terminal repeat confer superior magnitude of transcription and thereby the enhanced viral predominance
M Bachu, S Yalla, M Asokan, A Verma, U Neogi, S Sharma, RV Murali, ...
Journal of Biological Chemistry 287 (53), 44714-44735, 2012
SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung
NK Routhu, N Cheedarla, VS Bollimpelli, S Gangadhara, VV Edara, L Lai, ...
Nature communications 12 (1), 3587, 2021
A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs
NK Routhu, N Cheedarla, S Gangadhara, VS Bollimpelli, AK Boddapati, ...
Immunity 54 (3), 542-556. e9, 2021
Determinants of neutralizing antibody response after SARS CoV-2 vaccination in patients with myeloma
AK Nooka, U Shanmugasundaram, N Cheedarla, H Verkerke, VV Edara, ...
Journal of Clinical Oncology 40 (26), 3057, 2022
Seed inoculation with Bacillus spp. improves seedling vigour in oil-seed plant Jatropha curcas L.
S Desai, C Narayanaiah, CK Kumari, MS Reddy, SS Gnanamanickam, ...
Biology and Fertility of Soils 44, 229-234, 2007
Structural insights for neutralization of Omicron variants BA. 1, BA. 2, BA. 4, and BA. 5 by a broadly neutralizing SARS-CoV-2 antibody
S Kumar, A Patel, L Lai, C Chakravarthy, R Valanparambil, ES Reddy, ...
Science advances 8 (40), eadd2032, 2022
Sequence insertions in the HIV type 1 subtype C viral promoter predominantly generate an additional NF-κB binding site
M Bachu, AB Mukthey, RV Murali, N Cheedarla, A Mahadevan, ...
AIDS research and human retroviruses 28 (10), 1362-1368, 2012
Functional and protective role of neutralizing antibodies (NAbs) against viral infections
N Cheedarla, LE Hanna
Recent developments in applied microbiology and biochemistry, 83-93, 2019
Induction of circulating T follicular helper cells and regulatory T cells correlating with HIV-1 gp120 variable loop antibodies by a subtype C prophylactic vaccine tested in a …
S Munusamy Ponnan, S Swaminathan, K Tiruvengadam, V KK, ...
PloS one 13 (8), e0203037, 2018
Impaired SARS-CoV-2 Variant Neutralization and CD8+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough …
MI Azeem, AK Nooka, U Shanmugasundaram, N Cheedarla, S Potdar, ...
Blood Cancer Discovery 4 (2), 106-117, 2023
Nucleocapsid antigenemia is a marker of acute SARS-CoV-2 infection
HP Verkerke, GL Damhorst, DS Graciaa, K McLendon, W O’Sick, ...
The Journal of Infectious Diseases 226 (9), 1577-1587, 2022
Broad and potent cross clade neutralizing antibodies with multiple specificities in the plasma of HIV-1 subtype C infected individuals
N Cheedarla, KL Precilla, H Babu, KKV Vijayan, M Ashokkumar, ...
Scientific reports 7 (1), 46557, 2017
Modified vaccinia Ankara based SARS-CoV-2 vaccine expressing full-length spike induces strong neutralizing antibody response
NK Routhu, S Gangadhara, N Cheedarla, A Shiferaw, SA Rahman, ...
bioRxiv, 2020.06. 27.175166, 2020
The RADx tech test verification core and the ACME POCT in the evaluation of COVID-19 testing devices: A model for progress and change
EJ Nehl, SS Heilman, D Ku, DS Gottfried, S Farmer, R Mannino, ...
IEEE open journal of engineering in medicine and biology 2, 142-151, 2021
Molecular characteristics of the envelope of vertically transmitted HIV-1 strains from infants with HIV infection
M Ashokkumar, M Nesakumar, N Cheedarla, KK Vidyavijayan, H Babu, ...
AIDS research and human retroviruses 33 (8), 796-806, 2017
Blood group A enhances SARS-CoV-2 infection
SC Wu, CM Arthur, HM Jan, WF Garcia-Beltran, KR Patel, MF Rathgeber, ...
Blood 142 (8), 742-747, 2023
Antibody response, neutralizing potency, and transplacental antibody transfer following SARS‐CoV‐2 infection versus mRNA‐1273, BNT162b2 COVID‐19 vaccination in pregnancy
CM Dude, NT Joseph, AD Forrest, HP Verkerke, N Cheedarla, ...
International Journal of Gynecology & Obstetrics, 2023
A clade C HIV-1 vaccine protects against heterologous SHIV infection by modulating IgG glycosylation and T helper response in macaques
A Sahoo, AT Jones, N Cheedarla, S Gangadhara, V Roy, TM Styles, ...
Science immunology 7 (73), eabl4102, 2022
Structure-guided changes at the V2 apex of HIV-1 clade C trimer enhance elicitation of autologous neutralizing and broad V1V2-scaffold antibodies
A Sahoo, EA Hodge, CC LaBranche, TM Styles, X Shen, N Cheedarla, ...
Cell reports 38 (9), 2022
The system can't perform the operation now. Try again later.
Articles 1–20